NCT02532920 The Natural History of Atopic Disease in Thai Children and Association With Atopic March Status COMPLETED Phase N/A
NCT02525094 Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT02519556 Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children Status COMPLETED Phase PHASE4
NCT02504853 Natural History and Genetics of Food Allergy and Related Conditions Status RECRUITING Phase N/A
NCT02496546 An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) Status COMPLETED Phase PHASE1
NCT02475447 Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT02465606 A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT02456480 Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT02449850 Preventing Atopic Dermatitis and ALLergies in Children Status ACTIVE_NOT_RECRUITING Phase NA
NCT02424253 A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT02407756 A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema) Status COMPLETED Phase PHASE2
NCT02401178 The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in Infants Status COMPLETED Phase N/A
NCT02395133 A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD) Status COMPLETED Phase PHASE3
NCT02379910 A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE1/PHASE2
NCT02376049 A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD) Status COMPLETED Phase PHASE1
NCT02369432 Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis Status TERMINATED Phase EARLY_PHASE1
NCT02365246 Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD) Status RECRUITING Phase PHASE2
NCT02347176 Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT02345928 A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT02340234 A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2